Joshi Abhay 4
4 · Revance Therapeutics, Inc. · Filed Dec 17, 2019
Insider Transaction Report
Form 4
Joshi Abhay
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2019-12-14$15.99/sh−2,971$47,506→ 85,952 total
Footnotes (1)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on December 14, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award ("RSA") for 8,593 shares. The RSA vests in four equal annual installments from December 14, 2015, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Inducement Plan) on each vesting date.